Acetaminophen administration and the risk of acute kidney injury: a self-controlled case series study
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Acetaminophen (APAP) is frequently used for analgesia and is considered safer than nonsteroidal anti-inflammatory drugs (NSAIDs) for the kidneys. However, there is little epidemiological evidence of the association between APAP and acute kidney injury (AKI). OBJECTIVES: To examine the association between APAP and AKI using the self-controlled case series (SCCS) method, which is a novel strategy to control between-person confounders by comparing the risk and reference periods in each patient. METHODS: We performed SCCS in 1,871 patients (39.9% female) who were administered APAP and subsequently developed AKI, by reviewing electronically stored hospital information system data from May 2011 to July 2016. We used conditional Poisson regression to compare each patient's risk and reference period. As a time-varying confounder, we adjusted the status of liver and kidney functions, systemic inflammation, and exposure to NSAIDs. RESULTS: We identified 5,650 AKI events during the 260,549 person-day observation period. The unadjusted incidences during the reference and exposure periods were 2.01/100 and 3.12/100 person-days, respectively. The incidence rate ratio adjusted with SCCS was 1.03 (95% confidence interval [CI]: 0.95-1.12). When we restricted endpoints as stage 2 AKI- and stage 3 AKI-level creatinine elevations, the incidence rate ratios were 1.20 (95% CI 0.91-1.58) and 1.20 (95% CI 0.62-2.31), respectively, neither of which was statistically significant. CONCLUSION: Our findings added epidemiological information for the relationship between APAP administration and AKI development. The results indicated scarce association between APAP and AKI, presumably supporting the general physicians' impression that APAP is safer for kidney.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the contrary, therapeutic doses of paracetamol are generally safe and do not lead to acute renal failure in patients with renal impairment.89”
From An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact (2023) · cites this paper as [89]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Chou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718 · cited 1×
“8 Although there is quite limited epidemiological evidence for the association between therapeutic-dose APAP and AKI, guidelines, 9,10 textbook, 11 and even the National Kidney Foundation web page 12 describes its safer profile for the kidney, which is widely known among physicians.”
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
Chawla, L. S., Eggers, P. W., Star, R. A., & Kimmel, P. L. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1214243 · Cited by 1,977 · cited 1×
“24,25 9-12 Therefore, kidney function is also a time-varying confounder to be adjusted.”
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481 · cited 1×
“22 We assumed liver function impairment to be transient and to occur independently of the kidney injury.”
Chapter 1: Definition and classification of CKD
(2013) · Kidney International Supplements · doi:10.1038/kisup.2012.64 · Cited by 1,110
Mechanisms of Acetaminophen-Induced Liver Necrosis
Hinson, J. A., Roberts, D. W., & James, L. P. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00663-0_12 · Cited by 1,006
A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis
Cooper, B. A., Branley, P., Bulfone, L., Collins, J. F., Craig, J. C., Fraenkel, M. B., Harris, A., Johnson, D. W., Kesselhut, J., Li, J. J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000552 · Cited by 854 · cited 1×
“73 m(2) can be seen as end-stage renal disease (ESRD) patients.(19) The inclusion flow diagram is shown in Figure 2.”
Chronic Dialysis and Death Among Survivors of Acute Kidney Injury Requiring Dialysis
Wald, R. (2009) · JAMA · doi:10.1001/jama.2009.1322 · Cited by 780 · cited 1×
“AKI can sometimes be a lethal condition, 45 and it is also well known that those who recovered from AKI can progress to chronic kidney disease, 46 which is a major risk factor for cardiovascular diseases.”
Tutorial in biostatistics: the self‐controlled case series method
Whitaker, H. J., Paddy Farrington, C., Spiessens, B., & Musonda, P. (2006) · Statistics in Medicine · doi:10.1002/sim.2302 · Cited by 719 · cited 2×
“SCCS is a kind of case-series method developed recently.(15,16) The method compares incident rates during time periods with different risk statuses within each individual in order to estimate the incident rate ratio of risk factors.”
Cited by
Mallet, C., Desmeules, J., Pegahi, R., & Eschalier, A. (2023) · Journal of Pain Research · doi:10.2147/jpr.s393809 · Cited by 83
“On the contrary, therapeutic doses of paracetamol are generally safe and do not lead to acute renal failure in patients with renal impairment.(89) It was previously hypothesized that paracetamol may cause renal injury due to the reports of nephropathy after phenacetin overuse; however, this hypothesis was then rejecte…”
BackgroundAlchin, J., Dhar, A., Siddiqui, K., & Christo, P. J. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2049551 · Cited by 65
Toxicological Property of Acetaminophen: The Dark Side of a Safe Antipyretic/Analgesic Drug?
Ishitsuka, Y., Kondo, Y., & Kadowaki, D. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00722 · Cited by 63
Ding, Y., Zhong, R., Jiang, R., Yang, X., He, L., Yuan, L., & Cheng, D. (2023) · ACS Sensors · doi:10.1021/acssensors.2c02610 · Cited by 46
Roles of Hydrogen Sulfide Donors in Common Kidney Diseases
Ngowi, E. E., Sarfraz, M., Afzal, A., Khan, N. H., Khattak, S., Zhang, X., Li, T., Duan, S., Ji, X., & Wu, D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.564281 · Cited by 50
“APAP/paracetamol-induced nephrotoxicity is amongst the least causatives of renal injury (Hiragi et al., 2018).”
BackgroundEffects of hydrogen sulfide on acetaminophen-induced acute renal toxicity in rats
Özatik, F. Y., Tekşen, Y., Kadıoğlu, E., Özatik, O., & Bayat, Z. (2019) · International Urology and Nephrology · doi:10.1007/s11255-018-2053-0 · Cited by 36
Ruan, H., Wang, L., Wang, J., Sun, H., He, X., Li, W., & Zhang, J. (2019) · Journal of Food Biochemistry · doi:10.1111/jfbc.13067 · Cited by 23
Renal impairment and analgesia: From effectiveness to adverse effects
Alizadeh, R., & Aghsaiefard, Z. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28506 · Cited by 16
“Initially, acetaminophen was used to treat mild pain in CKD cases (Hiragi et al., 2018); however, various reports regarding its effects on renal failure are present (Ndetan et al., 2018).”
BackgroundLi, J., Li, T., Li, Z., Song, Z., & Gong, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1153297 · Cited by 20
“Acetaminophen-induced AKI (AP-AKI) is also caused by excessive or long-term use of acetaminophen; therefore, its pathology is usually ATN (Hiragi et al., 2018).”
BackgroundBaponwa, O., Amang, A. P., Mezui, C., Koubala, B. B., Siwe, G. T., Vandi, V. L., & Tan, P. V. (2022) · BioMed Research International · doi:10.1155/2022/1846558 · Cited by 18
Ikuta, K., Nakagawa, S., Yamawaki, C., Itohara, K., Hira, D., Imai, S., Yonezawa, A., Nakagawa, T., Sakuragi, M., Sato, N., et al. (2022) · BMC Nephrology · doi:10.1186/s12882-022-03008-x · Cited by 15
“73m2 because they were considered to have end-stage renal disease [22].”
BackgroundSelf-citationTrevisan, M., Fu, E. L., Xu, Y., Jager, K. J., Zoccali, C., Dekker, F. W., & Carrero, J. J. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa244 · Cited by 11
Ide, K., Fujiwara, T., Shimada, N., & Tokumasu, H. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02596-7 · Cited by 6
Nishimura, F., Ushijima, T., Nojima, M., Hamada, S., Hara, K., Hamada, Y., Kadowaki, D., Miyamura, S., Oniki, K., & Saruwatari, J. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b21-00215 · Cited by 4
Therapie rheumatischer Erkrankungen mit Niereninsuffizienz
Weiner, S. M. (2019) · Der Orthopäde · doi:10.1007/s00132-019-03807-5 · Cited by 6
Liu, C., Wang, W., Zhang, K., Liu, Q., Ma, T., Tan, L., & Ma, L. (2022) · Nutrients · doi:10.3390/nu14102077 · Cited by 7
“The mechanism of AKI damage caused by APAP is complex and primarily involves the production of toxic metabolic substances in vivo, oxidative stress, inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress [11,12].”
BackgroundIsolated paracetamol-induced acute kidney injury: a systematic review
North Bristol NHS Trust MB ChB MSc MRCP Consultant in Acute Medicine, Williams, M., & Coulson, J. (2022) · Acute Medicine Journal · doi:10.52964/amja.0904 · Cited by 6
Mitsuboshi, S., Yamada, H., Yamazaki, S., Kobayashi, M., Ueno, K., & Nagai, K. (2020) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.20-00010 · Cited by 5
Self-citationShim, J., Shin, D., Hong, S., Park, J., & Hong, S. H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144014 · Cited by 5
“In addition, it has advantages over non-steroidal anti-inflammatory drugs in patients at risk of postoperative bleeding or renal impairments [32].”
BackgroundSenocak, E. A., & Betül, A. Y. (2022) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2022.21.1.0385 · Cited by 4
“However, many studies reported that PRC might be caused by nephrotoxicity in long-term use [12, 41].”
BackgroundRole of Seaweeds in Drug Induced Nephrotoxicity
Sohail, N., & Farhat, H. (2022) · Marine Science and Technology Bulletin · doi:10.33714/masteb.1185059 · Cited by 3
“It causes acute renal failure in 1– 2% of patients (Canayakin et al., 2016; Hiragi et al., 2018).”
BackgroundVarela‐Santoyo, E., Escamilla-López, M. I., Izquierdo-Tolosa, C. D., Arroyave-Ramírez, A. M., Buerba-Vieregge, H. H., Dorantes-Heredia, R., Motola‐Kuba, D., & Ruiz-Morales, J. M. (2019) · Oncology · doi:10.1159/000504258 · Cited by 3
Early acetaminophen Use and 90-day mortality in ICU patients with ischemic stroke
Piao, Z.-S., Zhang, Y., Li, G., Jia, Y., & Cheng, K. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1622440 · Cited by 2
Liao, Y., Wang, Y., Li, D., & Qiu, X. (2024) · PLoS ONE · doi:10.1371/journal.pone.0314902 · Cited by 1
Şenocak, E. A., & Utlu, N. (2025) · Journal of Boron · doi:10.30728/boron.1595247 · Cited by 1
Волощук, О. М., & Kopylchuk, H. P. (2025) · Current Issues in Pharmacy and Medical Sciences · doi:10.12923/cipms-2025-0028 · Cited by 1
Dokumacıoğlu, E., İskender, H., Hayırlı, A., Yenice, G., Kapakin, K. A. T., Bolat, İ., & Kirman, E. M. (2023) · Makara Journal of Health Research · doi:10.7454/msk.v27i1.1438 · Cited by 1
“nephrotoxin and can induce nephrotoxicity at a single dose of its administration.(27,28) In APAP intoxication, increased levels of N-acetyl-p-benzoquinoneimine lead to increased formation of superoxide radicals (O2) and hydrogen peroxide (H2O2).”
BackgroundRenal toxicity after acetaminophen overdose
Akakpo, J. Y., & Ramachandran, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15877-3.00007-7 · Cited by 1
Nephrotoxicity by overdose of acetaminophen
Gjermeni, I., NELAJ, E., Kecaj, I., Gjermeni, E., & Tase, M. (2021) · Archives of the Balkan Medical Union · doi:10.31688/abmu.2021.56.4.15 · Cited by 1
“Acetaminophen is generally regarded as a safer drug regarding kidney function compared to non-steroidal anti-inflammatory drugs (NSAIDs), which are known to contribute to the development of AKI 6 .”
InfluentialXiang, C., Li, S., Zhang, J., Zhang, J., Hu, S., Pan, M., Yang, C., & Zhang, K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1079972 · Cited by 1
“Nowadays, many studies reported that improper use of acetaminophen, including excessive use and combining with other drugs inappropriately, would cause serious damages, including liver toxicity kidney toxicity and even death (Hiragi et al., 2018; Hopkins et al., 2018; Janković, 2022).”
BackgroundAnalgesic therapy and a problem of comorbidity
Karateev, A. E. (2019) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2019-3-116-125
Nondialytic Supportive Management of AKI
Yamada, H. (2020) · Springer eBooks · doi:10.1007/978-981-15-1108-0_16
Self-citationВолощук, О. М., & Kopylchuk, G. P. (2019) · Biolohichni systemy · doi:10.31861/biosystems2019.01.003
Predictive factors for liver and kidney injury in acetaminophen poisoning: A cross-sectional study
Meamar, R., Yazdi, R., Feizi, A., Namvar, M., Mirbod, S. A., & Eizadi‐Mood, N. (2025) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2025.07.010 · Cited by 1
Piao, Z.-S., Wang, Y.-F., & Cheng, K. (2026) · BMC Neurology · doi:10.1186/s12883-025-04553-2
“However, no significant association with AKI incidence was observed in patients with sepsis [18].”
Metadata
- Authors
- Hiragi, S., Yamada, H., Tsukomoto, T., Yoshida, K., Kondo, N., Matsubara, T., Yanagita, M., Tamura, H., & Kuroda, T.
- Affiliations
- Kyoto University (JP)
- Harvard University (US)
- Kyoto University Hospital (JP)
- Corresponding author
- Hiragi, Shusuke
- ORCID
- Venue
- Clinical Epidemiology
- Publisher
- Informa UK Limited
- Published
- 2018-03
- Volume
- Volume 10
- Pages
- 265-276
- ISSN
- 1179-1349 (ISSN-L)
- PMC
- PMC5846761
- OpenAlex
- W2793234939
- Cited by
- 35
- References
- 47
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 2 · 2020: 6 · 2019: 7
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Clinical Epidemiology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (16K12523)
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Nephrology › Nephrotoxicity and Medicinal Plants
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- paracetamol, acute kidney injury, drug safety, nonsteroidal anti-inflammatory drugs, self-controlled case series, time-varying confounding, creatinine elevation, analgesia, renal function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.